基于TaqMan探针的实时荧光定量PCR检测中成药中三七成分
本研究建立并验证了一种靶向三七的TaqMan探针实时荧光定量PCR方法,可特异性区分三七与人参、西洋参及温郁金,检测灵敏度达0.001 ng/μl DNA模板浓度;用该方法检测25批次中成药共75份样品,均确认含三七,提示该方法可用于中成药质量控制与市场监管。
要点
- TaqMan探针qPCR可特异性鉴别三七与人参、西洋参及温郁金。
- 该方法对三七DNA模板的检出限为0.001 ng/μl。
- 25批次共75份中成药样品经qPCR均确认含三七。
核心结论
- 基于TaqMan探针的qPCR方法能准确鉴定中成药中的三七成分,有望成为质量控制与市场监管的有力工具。
研究设计与样本
- 研究构建并验证了靶向三七的TaqMan探针qPCR检测方法,所用DNA提取自三七及掺伪品,并检测了来自25批次中成药的75份样品。
主要发现
- 所建qPCR方法可特异性区分三七与人参、西洋参和温郁金。
- 灵敏度研究显示该qPCR方法对三七的可检出DNA模板浓度为0.001 ng/μl。
- 75份中成药样品经qPCR检测均确认含有三七。
关键数值与推荐
- 特异性验证对象为人参、西洋参和温郁金。
- 三七DNA模板可检出浓度为0.001 ng/μl。
- 检测样品为来自25批次中成药的75份样品。
临床怎么用
- 该qPCR方法可用于中成药中三七成分的定性检测,辅助质量控制和市场监管。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: There has been global concern about the safety and accuracy of traditional Chinese patent medicines (TCPMs). Panax notoginseng, also known as sanqi, is an important constituent of TCPMs. However, identifying the species contained in TCPMs is challenging due to the presence of multiple ingredients and the use of various preparation processes. Objective: To detect P. notoginseng in TCPMs. Methods: A TaqMan probe-based qPCR assay was constructed and validated with DNA extracted from P. notoginseng and adulterants. In total, 75 samples derived from 25 batches of TCPMs were tested using the constructed qPCR method. Results: A TaqMan probe-based qPCR assay targeting P. notoginseng was established. The constructed qPCR assay could specifically discriminate P. notoginseng from Panax ginseng, Panax quinquefolium and Curcuma aromatica Salisb. cv. Wenyujin. The sensitivity study showed that the detectable DNA template concentration of P. notoginseng for this qPCR assay was 0.001 ng/μl. All 75 samples from TCPMs were confirmed to contain P. notoginseng by the qPCR assay. Conclusions: The qPCR method can accurately identify P. notoginseng in TCPMs and is promising as a powerful tool for quality control and market regulation.
引用
- Lou Q, Xin T, Xu W, et al. TaqMan Probe-Based Quantitative Real-Time PCR to Detect Panax notoginseng in Traditional Chinese Patent Medicines. Front Pharmacol. 2022. PMID: 35685641. doi:10.3389/fphar.2022.828948
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。